PE/FITC/APC/Biotin-Conjugated CLDN18.2 Antibody for Cell Analysis

Claudin 18.2 (CLDN18) is a tight junction protein isoform selectively expressed on gastric and pancreatic cancer cells with highly restricted normal tissue expression. CLDN18.2 is a clinically leading solid tumor target for antibodies and CAR-T.

Order information

Catalog No.Product NameConjugateSizePrice (In USD)
GM-Tg-hg-T65883-Ab-3-PEAnti-Human Claudin 18/CLDN18 monoclonal antibody(mAb)(PE)PE25T
GM-Tg-hg-T65883-Ab-3-PEAnti-Human Claudin 18/CLDN18 monoclonal antibody(mAb)(PE)PE100T
GM-Tg-hg-T65883-Ab-3-PEAnti-Human Claudin 18/CLDN18 monoclonal antibody(mAb)(PE)PE500T
GM-Tg-hg-T65883-Ab-3-FITCAnti-Human Claudin 18/CLDN18 monoclonal antibody(mAb)(FITC)FITC25T
GM-Tg-hg-T65883-Ab-3-FITCAnti-Human Claudin 18/CLDN18 monoclonal antibody(mAb)(FITC)FITC100T
GM-Tg-hg-T65883-Ab-3-FITCAnti-Human Claudin 18/CLDN18 monoclonal antibody(mAb)(FITC)FITC500T
GM-Tg-hg-T65883-Ab-3-APCAnti-Human Claudin 18/CLDN18 monoclonal antibody(mAb)(APC)APC25T
GM-Tg-hg-T65883-Ab-3-APCAnti-Human Claudin 18/CLDN18 monoclonal antibody(mAb)(APC)APC100T
GM-Tg-hg-T65883-Ab-3-APCAnti-Human Claudin 18/CLDN18 monoclonal antibody(mAb)(APC)APC500T
GM-Tg-hg-T65883-Ab-3-BiotinAnti-Human Claudin 18/CLDN18 monoclonal antibody(mAb)(Biotin)Biotin25T, 100T, 500T

Description

TargetCLDN18.2 (specific biomarker for human gastric/pancreatic adenocarcinoma cell)
SpeciesHumanized
Expression platformMammalian cell
IsotypesHuman IgG
TaghFc
ConjugatePE / FITC / APC / Biotin
Size25T / 100T / 500T
Purity>=95% (SDS-PAGE)
Bioactivity validationCLDN18.2 binding, FACS in CLDN18.2 level test
ApplicationFACS and other Immunoassay for CLDN18.2 test
Products descriptionAnti-Human Claudin 18/CLDN18 monoclonal antibody(mAb)(PE/FITC/APC/Biotin) is a recombinant monoclonal antibody. It specifically recognizes CLDN18.2 (tight-junction protein claudin-18.2 specifically exposed in GI adenocarcinomas). CLDN18.2 is a gastric/pancreatic adenocarcinoma cell marker. This antibody is validated by FACS for solid-tumor target assessment for CLDN18.2 CAR-T. It is recommended for multi-color flow cytometry panels to validate CLDN18.2 expression for gastric/pancreatic CAR-T screening in CAR-T cell therapy manufacturing, QC and functional assessment.
Formulation & ReconstitutionLyophilized from sterile PBS, pH 7.4
StorageStore at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.



<